Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients.
about
Cellular and molecular basis of deiodinase-regulated thyroid hormone signalingHypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in ratsDeiodinases: implications of the local control of thyroid hormone actionThyroid Hormones, Oxidative Stress, and InflammationScope and limitations of iodothyronine deiodinases in hypothyroidismThyroid hormones and skeletal muscle--new insights and potential implicationsAbnormalities of Thyroid Hormone Metabolism during Systemic Illness: The Low T3 Syndrome in Different Clinical SettingsType 3 deiodinase: role in cancer growth, stemness, and metabolismThe thyroid hormone-inactivating deiodinase functions as a homodimerGuidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacementTriumphs of the thyroid despite lesser conversionThyroid hormones regulate selenoprotein expression and selenium status in mice.Is a low level of free thyroxine in the maternal circulation associated with altered endothelial function in gestational diabetes?Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke.IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cellsMice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis.Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.Type 2 iodothyronine deiodinase levels are higher in slow-twitch than fast-twitch mouse skeletal muscle and are increased in hypothyroidism.Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humansClinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?N-acetylcysteine administration prevents nonthyroidal illness syndrome in patients with acute myocardial infarction: a randomized clinical trialIdentification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock.Reawakened interest in type III iodothyronine deiodinase in critical illness and injury.Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challengesThe central effects of thyroid hormones on appetite.Role of type 2 deiodinase in response to acute lung injury (ALI) in mice.Type 2 deiodinase and host responses of sepsis and acute lung injuryEndocrine changes in critical illness.Sleep deprivation in critical illness: its role in physical and psychological recoveryEndocrine modifications and interventions during critical illness.Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processesTissue-Specific Suppression of Thyroid Hormone Signaling in Various Mouse Models of AgingAbsence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in miceCaloric restriction induces energy-sparing alterations in skeletal muscle contraction, fiber composition and local thyroid hormone metabolism that persist during catch-up fat upon refeeding.Effect of tight glucose control with insulin on the thyroid axis of critically ill children and its relation with outcomeCatalysis leads to posttranslational inactivation of the type 1 deiodinase and alters its conformationEffects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.Genomic imprinting of the type 3 thyroid hormone deiodinase gene: regulation and developmental implications.Decreased translation of Dio3 mRNA is associated with drug-induced hepatotoxicity.Impaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae.
P2860
Q24648381-1593EDDB-A97F-41D1-B904-756F12F697D9Q24653981-A731F7DE-0E1D-4796-80BF-D67AB2215750Q24669858-2AC03A27-2CD6-421B-B7CE-359658799E5FQ26751365-3EAC91A3-744D-4C3B-A8E5-DBBE5FE795D4Q26785400-9CAFB45C-EAF0-448C-979E-121E9F8BE0E3Q26991631-BB0B9C8D-7227-40AF-972F-A9F033E415ECQ28067543-2A62D359-AAD3-4BEC-80DB-07D889E01E86Q28080881-14CDE557-4827-4439-B7F7-7B7DAA8564B8Q28273439-95C30445-E3CA-4709-80C7-60F56EE3EBC0Q28649731-53CC86C6-0FCB-4DA8-AF3C-BC9A0E6BB57CQ33569573-7DA33D33-1469-4F55-8363-E8362020E1DDQ33705074-48A81F92-FCC4-4C12-893E-E06F7909C530Q33719410-1BAE98BD-DF90-463A-8BE4-18B607DDADE6Q34109447-AAE090A6-663D-42AB-AAFF-AB6E51AB90ABQ34182213-DCCEA5AC-EF52-48D8-922F-85FE82317BB5Q34185721-ADFA311F-AC44-457E-8103-1560C9D01BEBQ34226270-C13BE32A-0111-43CD-B106-34753DAC0ED6Q34392574-5DC8C1C8-E077-42B9-A8AD-C3E1D896C85AQ34446531-C74B24BB-0813-43FD-8F0D-2A26945FFE35Q34529617-B7C8231C-D3E0-4E7C-A1DE-C2FF9CEAD00CQ34628326-A07C491C-AB94-4B38-A338-F60235E8E571Q34710972-8CE8DAD9-06F8-408D-AEC7-13EE77D72EB8Q34739557-CFA91A23-68D2-43BB-8850-1A01AD8B2E45Q34932671-9B8C5DB9-3FB1-47DD-A123-CBB9624B6A0AQ35038827-8DF41DA9-6309-4231-AA51-C24C0CDCD22CQ35621354-5503F631-0622-4BB3-9A4B-A5BCE8BD7CC8Q35684795-C63DF198-5CF7-4179-81B7-D0DE58A1F27CQ35740551-48681AEC-3A23-41F3-8025-E48C0BA49CA4Q35823371-C3ED8D91-B763-4E03-A097-D1997076B8F2Q35890474-6CEB905D-FB64-4CA1-B14A-0CC719655ED9Q35947049-850A57DA-6C4F-4A8A-8A9A-B1978C12D6C6Q35948855-D6C59C52-BEC7-4889-9E90-3D3E36860224Q35970123-9A17FF9F-ACEB-4220-93ED-B146C56DCAABQ36097430-AF99E189-F59D-4FD3-8D65-F03E707C4C55Q36293600-784BE7C4-0E26-4270-B15E-F05A7121DB63Q36730768-95CC0DF7-CE40-42C1-8347-B8A37FBE4B20Q36796581-F3DBBCFA-29F6-4047-8DA0-2182CB367428Q36831907-21DCCA7C-C0E1-484C-8D21-DE83CAA93E45Q36929530-643149DC-357A-424A-BFD7-F62532E18A7FQ37136923-E3B2D4F4-B174-43CF-AC7C-EE6E7F67E46A
P2860
Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Reduced activation and increas ...... es of critically ill patients.
@en
Reduced activation and increas ...... es of critically ill patients.
@nl
type
label
Reduced activation and increas ...... es of critically ill patients.
@en
Reduced activation and increas ...... es of critically ill patients.
@nl
prefLabel
Reduced activation and increas ...... es of critically ill patients.
@en
Reduced activation and increas ...... es of critically ill patients.
@nl
P2093
P356
P1476
Reduced activation and increas ...... es of critically ill patients.
@en
P2093
Ellen Kaptein
Hans van Toor
Pieter J Wouters
Robin P Peeters
Theo J Visser
P304
P356
10.1210/JC.2002-022013
P407
P577
2003-07-01T00:00:00Z